The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial.

Fitzal, F; Filipits, M; Rudas, M; Greil, R; Dietze, O; Samonigg, H; Lax, S; Herz, W; Dubsky, P; Bartsch, R; Kronenwett, R; Gnant, M; Br J Cancer. 2015; 112(8):1405-1410

Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Stage 1 results of a phase II trial (AGMT MBC-6)

Rinnerthaler, G; Gampenrieder, SP; Fridrik, M; Petzer, A; Hubalek, M; Petru, E; Jager, T; Andel, J; Balic, M; Ulmer, H; Mlineritsch, B; Greil, R CANCER RES. 2016; 76:

CRISPR/Cas9-mediated gene correction of COL7A1 in dystrophic epidermolysis bullosa

Hainzl, S; Kocher, T; Murauer, EM; Larcher, F; Steiner, M; Bauer, JW; Koller, U HUM GENE THER. 2016; 27(11): A144-A144.

CRISPR/Cas9-mediated gene repair in the COL7A1 gene

Hainzl, S; Kocher, T; Murauer, EM; Larcher, F; Steiner, M; Bauer, JW; Reichelt, J; Koller, U J INVEST DERMATOL. 2016; 136(9): S189-S189.

R-EFECT: A multicenter, retrospective evaluation of CML therapy in Austria assessing the impact of early treatment response on patient outcomes in a real-life setting

Petzer, A; Herndlhofer, S; Weltermann, A; Sliwa, T; Schmidt, S; Greil, R; Molfler, A; Wiesholzer, M; Dormann, C; Thaler, J; Tinchon, C; Ruckser, R; Lang, A; Hanig, J; Winiger, I; Muenchmeier, N; Sperr, WR ONCOL RES TREAT. 2016; 39: 58-58.

Much less treatment modification with recently approved drugs: the Austrian HIV Cohort Study

Rappold, M; Rieger, A; Schmied, B; Sarcletti, M; Geit, M; Haas, B; Taylor, N; Kanatschnig, M; Leierer, G; Ledergerber, B; Zangerle, R J INT AIDS SOC. 2016; 19:

Analysis of ambient influences affecting Interleukin-6 as a paracrine mediator in clinical trials of stem cell therapy for myocardial infarction

Edlinger, C; Wernly, B; Leisch, M; Kammler, J; Kypta, A; Eder, S; Wuppinger, T; Moesenlechner, T; Ausserwinkler, M; Jung, C; Hoppe, UC; Lichtenauer, M EUR HEART J. 2016; 37: 515-516.

The impact of adjuvant denosumab on disease-free survival: Results from 3,425 postmenopausal patients of the ABCSG-18 trial

Gnant, M; Pfeiler, G; Dubsky, PC; Hubalek, M; Greil, R; Jakesz, R; Wette, V; Balic, M; Haslbauer, F; Melbinger-Zeinitzer, E; Bjelic-Radisic, V; Artner-Matuschek, S; Fitzal, F; Marth, C; Sevelda, P; Mlineritsch, B; Steger, GG; Manfreda, D; Exner, R; Egle, D; Bergh, J; Kainberger, F; Talbot, S; Warner, D; Fesl, C; Singer, CF CANCER RES. 2016; 76:

Tissue microRNAs predicting the pattern of breast cancer metastases

Gampenrieder, SP; Hackl, H; Rinnerthaler, G; Steiner, M; Hufnagl, C; Hauser-Kronberger, C; Mlineritsch, B; Greil, R EUR J CANCER. 2016; 57: S111-S111.

Calcipotriol treatment enhances wound closure and antimicrobial defense in recessive dystrophic epidermolysis bullosa in vitro while inhibiting proliferation and clonogenicity of RDEB cancer cells.

Tockner, B; Scharler, C; Huttner, C; Zurl, A; Strunk, D; Bauer, JW; Reichelt, J; Lang, R; Gruber, C; Hofbauer, JP MOL BIOL CELL. 2016; 27: